MIFH
SGMO

Migdal Insurance & Financial Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-68,776
Closed -$862K – 667
2021
Q1 		$862K Buy
68,776
+42,680
+164% +$575K 0.01% 257
2020
Q4 		$407K Buy
+26,096
New +$306K ﹤0.01% 237

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Migdal Insurance & Financial Holdings's SGMO Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2021, closing a stake of 68,776 shares — an estimated $862K sold.

Migdal Insurance & Financial Holdings first reported a position in SGMO in Q4 2020 and held it in 2 quarters. The position peaked at $862K in Q1 2021. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 68,776 SANGAMO THERAPEUTICS INC shares in Q2 2021, an estimated $862K.
  • Migdal Insurance & Financial Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's SANGAMO THERAPEUTICS INC position peaked at $862K in Q1 2021.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.